Simple Summary There is an urgent need for a non-invasive, specific biomarker to identify
patients at risk of chemoresistance, which it is the ability of cancer cells to escape the effect …

Introduction Residual tumor cellularity (RTC) and pathologic complete response (pCR) after
neo-adjuvant chemotherapy (NAC) are prognostic factors associated with improved …

Substantial advances have been made in the systemic treatment of breast cancer with
residual disease following neoadjuvant therapy. We reviewed recent and ongoing studies …

Senescence is a cell stress response induced by replicative, oxidative, oncogenic, and
genotoxic stresses. Tumor cells undergo senescence in response to several cancer …

Background Pathological complete response (pCR) is associated with favorable prognosis
in patients with triple-negative breast cancer (TNBC). However, only 30–40% of TNBC …

Simple Summary One out of 8 breast cancers is of a particular type called “HER2-positive”,
which is more aggressive and is treated by surgery and a medical treatment associating …

Background/Aim: Prior studies have underlined the prognostic relevance of pathological
complete response (pCR) after neoadjuvant chemotherapy (NAC) in breast cancer …

PURPOSE The optimal characteristics among patients with breast cancer to recommend
neoadjuvant chemotherapy is an active area of clinical research. We developed and …

Purpose To compare the diagnostic performance for pathologic complete response (pCR) in
breast cancer after neoadjuvant chemotherapy (NAC) between ultrasound (US) and …

Objective Timely diagnosis of breast cancer can ameliorate the treatment plan, thus
reducing the mortality rate. We propose a model integrating pre-trained Convolutional …